A growing body of evidence is shifting expert opinion toward supporting MS treatment during pregnancy, emphasizing ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

Lurbinectedin and atezolizumab performed better than atezolizumab alone as maintenance therapy for extensive-stage small cell lung cancer.

The UK Government is pushing itself to become a world leader in AI-powered drug discovery with new investments and global ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase III ...

Genentech’s short film draws on the experiences of multiple families caring for children with hemophilia A, seeking to ...

Genentech has announced plans to build a new biotechnology manufacturing plant in Holly Springs, North Carolina. The company, ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall ...

With a background in biochemistry, Erica Taylor admits her route into marketing is not common, but it has given her a unique ...